NUCLEAR-DNA CONTENT AS A PROGNOSTIC FACTOR IN T1-2N0 BREAST-CANCER

被引:44
作者
TOIKKANEN, S [1 ]
JOENSUU, H [1 ]
KLEMI, P [1 ]
机构
[1] UNIV TURKU, CENT HOSP, DEPT RADIOTHERAPY, SF-20520 TURKU 52, FINLAND
关键词
Breast cancer; Flow cytometry; Long-term survival; Prognostic factors;
D O I
10.1093/ajcp/93.4.471
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
One hundred fifteen patients with postsurgical stage T1-2N0 breast cancer with the minimum follow-up of 22 years and from a defined population were studied to find reliable prognostic factors predicting long-term survival rate. The 30-year survival rate corrected for intercurrent deaths was 75%, and no deaths of breast cancer occurred after the nineteenth year of follow-up. The 30-year crude survival rate was only 28%, indicating that the great majority of these patients ultimately die of other causes than breast cancer. The nuclear DNA content could be determined by flow cytometry in 95 of the 115 cases, and 52 (55%) of them were nondiploid. DNA ploidy (diploid vs. nondiploid, P = 0.11) did not have a significant influence on long-term survival rate, but cancers with the DNA index less than 1.2 had more favorable prognosis in a univariate analysis than those with the DNA index more than 1.2 (P = 0.02). The most important independent prognostic factor in Cox's multivariate analysis was the presence of lymphatic vessel invasion of cancer cells (P < 0.001). Several other factors, including histologic grade and type, extent of necrosis, type of tumor margin, age at diagnosis, and primary tumor size could be shown to be of prognostic value in univariate and/or multivariate analyses.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 50 条
  • [41] Conservative surgery for T2&gt;3 cm, T3 N0N1 M0 breast cancer after induction chemotherapy
    Bobin, JY
    Zinzindohoue, C
    Virelizier, CF
    Joulai, A
    Khaled, M
    BULLETIN DU CANCER, 2001, 88 (02) : 175 - 180
  • [42] C-ERBB-2 OVEREXPRESSION IN PRIMARY BREAST-CANCER - INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS AT HIGH-RISK
    SCHONBORN, I
    ZSCHIESCHE, W
    SPITZER, E
    MINGUILLON, C
    MOHNER, M
    EBELING, K
    GROSSE, R
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (03) : 287 - 295
  • [43] ROUTINE BONE SCANNING IN PATIENTS WITH T1 AND T2 BREAST-CANCER - A WASTE OF MONEY
    YEH, KA
    FORTUNATO, L
    RIDGE, JA
    HOFFMAN, JP
    EISENBERG, BL
    SIGURDSON, ER
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (04) : 319 - 324
  • [44] Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers
    Musolino, Antonino
    Boggiani, Daniela
    Sikokis, Angelica
    Rimanti, Anita
    Pellegrino, Benedetta
    Vattiato, Rosa
    Sgargi, Paolo
    Falcini, Fabio
    Caminiti, Caterina
    Michiara, Maria
    Leonardi, Francesco
    CANCER TREATMENT REVIEWS, 2016, 43 : 1 - 7
  • [45] Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients
    Zhang, Yuanxin
    Li, Ji
    Fan, Yuan
    Li, Xiaomin
    Qiu, Juanjuan
    Zhu, Mou
    Li, Hongjiang
    MEDICINE, 2019, 98 (40)
  • [46] PROGNOSTIC VALUE OF CELLS WITH MORE THAN 5C DNA CONTENT IN NODE-NEGATIVE BREAST-CANCER AS DETERMINED BY IMAGE CYTOMETRY FROM TISSUE-SECTIONS
    SIITONEN, SM
    KALLIONIEMI, OP
    ISOLA, JJ
    HUMAN PATHOLOGY, 1993, 24 (12) : 1348 - 1353
  • [47] T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy
    Kaplan, Henry G.
    Malmgren, Judith A.
    Atwood, Mary
    BREAST JOURNAL, 2009, 15 (05) : 454 - 460
  • [48] Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer:: multicentric retrospective study II.: DNA-ploidy and S-phase fraction
    Chassevent, A
    Jourdan, ML
    Ferrero-Poüs, M
    Colonna, M
    Romain, S
    Spyratos, F
    Roth, H
    Bolla, M
    BULLETIN DU CANCER, 1999, 86 (7-8) : 685 - 691
  • [49] PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN AND C-ERBB-2 COMPARED WITH CONVENTIONAL HISTOPATHOLOGICAL FACTORS IN BREAST-CANCER
    SCHONBORN, I
    ZSCHIESCHE, W
    MINGUILLON, C
    SPITZER, E
    MOHNER, M
    EBELING, K
    GROSSE, R
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (02) : 115 - 122
  • [50] Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms
    Ohmori, Yukimi
    Nomura, Takashi
    Fukushima, Norimasa
    Takahashi, Fumiaki
    Iwaya, Takeshi
    Koeda, Keisuke
    Nishizuka, Satoshi S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1154 - 1161